Knowde Enhanced TDS
Identification & Functionality
- Ingredient Name
- Food Ingredients Functions
- Pharma & Nutraceuticals Functions
- Ingredients
- Boswellia Extract, Boswellic Acid
Features & Benefits
- Labeling Claims
- The focus is on AKBA
5-LOXIN®’s safety is supported by historic usage, published human studies and a full complement of safety and toxicity studies.
5-LOXIN is presented in alliance with Laila Nutra, a division of the Laila Group, with business interests across sectors such as pharmaceuticals, nutraceuticals, ayurvedic products and other areas. 5-LOXIN was developed at Laila Nutraceuticals R&D, which is a 75,000 square foot R&D facility with 150 scientists, including 30 PhDs. Laila Nutra is a leader in process development for standardized herbal extracts and phytochemicals, as well as the isolation and characterization of marker compounds.
- Boswellic acids are natural, selective 5-lipoxygenase inhibitors. 3-O-acetyl-11-keto-ß-boswellic acid or “AKBA” is the most active.
- 5-LOXIN® provides a higher concentration of AKBA, standardized to 30%.
- In a recent human study, both 100mg and 250mg of 5-LOXIN® daily provided improvement in joint comfort and mobility within 7 days.
- 5-LOXIN® provided significant benefits in WOMAC, VAS and LFI standardized testing methodologies for joint health.
- 5-LOXIN® positively impacted biological markers associated with joint and general health, including TNFa, CRP, and IL-6.
- 5-LOXIN® was shown to significantly inhibit matrix metalloproteinase (MMP-3), enzymes that break down cartilage, collagen and connective tissues.
- 5-LOXIN® is well-tolerated, easy on the stomach and supported by extensive safety data.
Applications & Uses
- Markets
- Applications
- Food & Nutrition Applications
Regulatory & Compliance